References
- Lebovitz HE. Stepwise and combination drug therapy for the treatment of NIDDM. Diabetes Care 1994; 17: 1542–1544.
- Lebovitz HE. Type 2 diabetes: an overview. Clin Chem 1999; 45: 1339–1345.
- Borgström B, Wieloch T, Erlanson-Albertsson C. Evidence for a pancreatic pro-colipase and its activation by trypsin. FEBS Lett 1979; 108: 407–410.
- Erlanson-Albertsson C, Mei J, Okada S, York D, Bray GA. Pancreatic procolipase propeptide, enterostatin, specifically inhibits fat intake. Physiol Behav 1991; 49: 1191–1194.
- Mei J, Cheng Y, Erlanson-Albertsson C. Enterostatin - its ability to inhibit insulin secretion and to decrease high-fat food intake. Int J Obes Relat Metab Disord 1993; 17: 701–704.
- Berger K, Sivars U, Sörhede-Winzell M, et al. Mitochondrial ATP synthase - a possible target protein in the regulation of energy metabolism in vitro and in vivo. Nutrit Neurosci 2002; 5:, 201–210.
- Sörhede M, Erlanson-Albertsson C, Mei J, Nevalainen T, Aho A, Sundler F. Enterostatin in gut endocrine cells - immunocytochemical evidence. Peptides 1996; 17: 609–614.
- Lin L, York DA. Amygdala enterostatin induces c-fos expression in regions of hypothalamus that innervate the PVN. Brain Res 2004; 1020: 147–153.
- Park M, Lin L, Thomas S, et al. The F(1)-ATPase beta-subunit is the putative enterostatin receptor. Peptides 2004; 25: 2127–2133.
- Berger K, Winzell MS, Mei J, Erlanson-Albertsson C. Enterostatin and its target mechanisms during regulation of fat intake. Physiol Behav 2004; 83: 623–630.
- Martinez LO, Jacquet S, Esteve JP et al. Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis. Nature 2003; 421: 75–79.
- Moser TL, Stack MS, Asplin I, et al. Angiostatin binds ATP synthase on the surface of human endothelial cells. Proc Natl Acad Sci USA 1999; 96: 2811–2816.
- Kim BW, Choo HJ, Lee JW, Kim JH, Ko YG. Extracellular ATP is generated by ATP synthase complex in adipocyte lipid rafts. Exp Mol Med 2004; 36: 476–485.
- Yang J, Wong RK, Wang X, et al. Leucine culture reveals that ATP synthase functions as a fuel sensor in pancreatic beta-cells. J Biol Chem 2004; 279: 53915–53923.
- Greenwood FC, Hunter WM, Glover JS. The preparation of I-131- labelled human growth hormone of high specific radioactivity. Biochem J1963; 89: 114–123.
- Ookuma M, York DA. Inhibition of insulin release by enterostatin. Int J Obes Relat Metab Disord 1998; 22: 800–805.
- Lin L, York DA. Chronic ingestion of dietary fat is a prerequisite for inhibition of feeding by enterostatin. Am J Physiol 1998; 275: R619 -R623.
- Park MJ, Hulver M, York DA. Studies of enterostatin in signalling in HepG2 cells and human myocytes. Peripheral-Central Interactions in the Control of Food Intake and Energy Intake, Centro Stefano Franscini Ascona, Switzerland, 2005.
- Field KA, Holowka D, Baird B. Compartmentalized activation of the high affinity immunoglobulin E receptor within membrane domains. J Biol Chem 1997; 272: 4276–4280.
- Lin L, Umahara M, York DA, Bray GA. Beta-casomorphins stimulate and enterostatin inhibits the intake of dietary fat in rats. Peptides 1998; 19: 325–331.